Reslizumab
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-P9949-1 mg |
| CAS # | 241473-69-8 |
| Pricing | 1 mg, USD $1000.0 |
| Biological Activity | Reslizumab (Sch 55700) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab is effective in neutralizing the function of IL-5. Reslizumab inhibits IL-5-dependent cell proliferation, with an IC50 value of approximately 91.1pM. Reslizumab has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively[1][2]. |
| Purity | ≥99.4% |
| Synonyms | Sch 55700 |